Table 2 Secondary outcomes
Parameter | Method of analysis |
|---|---|
Coll2-1 | Decrease between inclusion (D-10) and D30 or D180 |
Lequesne index (LI) | Decrease between inclusion visit (D-10) and further visits |
Global assessment of pain | Visual analog scale (VAS, 0–100 mm) between inclusion visit (D-10) and further visits |
OMERACT/OARSI set of criteria | Percentage of responders at D90 and D180 |
Acetaminophen and NSAID consumption | Number of patients that required at least once rescue medication during the study |
Patient’s global assessment of the disease activity | 11 points Likert scale ranging of 0 (low active disease) to 10 (maximum activity) |